Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320490014> ?p ?o ?g. }
- W4320490014 endingPage "453" @default.
- W4320490014 startingPage "442" @default.
- W4320490014 abstract "A cure for Crohn's disease (CD), a chronic inflammatory disease of the gastrointestinal tract of unknown etiology, is not available, so patients require lifelong management to keep inflammation under control. The therapeutic armamentarium has expanded with approval of several biological drugs, including infliximab, adalimumab, vedolizumab and ustekinumab – monoclonal antibodies that target different inflammatory pathways – and darvadstrocel, a suspension of expanded human allogeneic, adipose-derived, mesenchymal stromal cells for the treatment of refractory complex perianal fistula. Notwithstanding existing practice guidelines on medical therapy for CD, the Italian Group for the Study of Inflammatory Bowel Disease felt the need to issue new guidelines focused on the use of biologics for managing the intestinal manifestations of CD and based on the GRADE methodology. This document presents recommendations regarding six clinical settings, from the induction to the maintenance of clinical remission, and from optimization and de-escalation of treatments to dealing with perianal CD and post-operative recurrence. The 19 evidence-based statements are supported by information on the quality of the evidence, agreement rate among panel members, and panel comments mainly based on evidence from real world studies." @default.
- W4320490014 created "2023-02-14" @default.
- W4320490014 creator A5005051512 @default.
- W4320490014 creator A5005055630 @default.
- W4320490014 creator A5005285250 @default.
- W4320490014 creator A5006423795 @default.
- W4320490014 creator A5007719681 @default.
- W4320490014 creator A5008725400 @default.
- W4320490014 creator A5008838958 @default.
- W4320490014 creator A5010932748 @default.
- W4320490014 creator A5012646641 @default.
- W4320490014 creator A5014964540 @default.
- W4320490014 creator A5016678827 @default.
- W4320490014 creator A5018969457 @default.
- W4320490014 creator A5019327502 @default.
- W4320490014 creator A5019495111 @default.
- W4320490014 creator A5026242246 @default.
- W4320490014 creator A5026747519 @default.
- W4320490014 creator A5028673698 @default.
- W4320490014 creator A5030492974 @default.
- W4320490014 creator A5030951086 @default.
- W4320490014 creator A5032297774 @default.
- W4320490014 creator A5032304413 @default.
- W4320490014 creator A5033486739 @default.
- W4320490014 creator A5040063565 @default.
- W4320490014 creator A5040818753 @default.
- W4320490014 creator A5043839163 @default.
- W4320490014 creator A5044577178 @default.
- W4320490014 creator A5047209658 @default.
- W4320490014 creator A5047563454 @default.
- W4320490014 creator A5049068984 @default.
- W4320490014 creator A5050089211 @default.
- W4320490014 creator A5052017294 @default.
- W4320490014 creator A5055148624 @default.
- W4320490014 creator A5057747766 @default.
- W4320490014 creator A5058934291 @default.
- W4320490014 creator A5058946827 @default.
- W4320490014 creator A5060056767 @default.
- W4320490014 creator A5066459416 @default.
- W4320490014 creator A5067892973 @default.
- W4320490014 creator A5068554238 @default.
- W4320490014 creator A5070038178 @default.
- W4320490014 creator A5071325068 @default.
- W4320490014 creator A5072928451 @default.
- W4320490014 creator A5073776627 @default.
- W4320490014 creator A5076294545 @default.
- W4320490014 creator A5076460185 @default.
- W4320490014 creator A5076872185 @default.
- W4320490014 creator A5079090669 @default.
- W4320490014 creator A5080352321 @default.
- W4320490014 creator A5080410805 @default.
- W4320490014 creator A5080965370 @default.
- W4320490014 creator A5085647688 @default.
- W4320490014 creator A5086201689 @default.
- W4320490014 creator A5087405062 @default.
- W4320490014 creator A5088008401 @default.
- W4320490014 creator A5088074320 @default.
- W4320490014 date "2023-04-01" @default.
- W4320490014 modified "2023-09-29" @default.
- W4320490014 title "Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology" @default.
- W4320490014 cites W1547943993 @default.
- W4320490014 cites W2019062711 @default.
- W4320490014 cites W2031860350 @default.
- W4320490014 cites W2049827204 @default.
- W4320490014 cites W2096675088 @default.
- W4320490014 cites W2120539905 @default.
- W4320490014 cites W2129558176 @default.
- W4320490014 cites W2143747121 @default.
- W4320490014 cites W2168056382 @default.
- W4320490014 cites W2325342792 @default.
- W4320490014 cites W2404971681 @default.
- W4320490014 cites W2525802576 @default.
- W4320490014 cites W2593398029 @default.
- W4320490014 cites W2789496884 @default.
- W4320490014 cites W2804630856 @default.
- W4320490014 cites W2806806868 @default.
- W4320490014 cites W2887206736 @default.
- W4320490014 cites W2894877589 @default.
- W4320490014 cites W2916794721 @default.
- W4320490014 cites W2918314896 @default.
- W4320490014 cites W2920997743 @default.
- W4320490014 cites W2996580680 @default.
- W4320490014 cites W3008150080 @default.
- W4320490014 cites W3014838615 @default.
- W4320490014 cites W3022184092 @default.
- W4320490014 cites W3026683463 @default.
- W4320490014 cites W3027973540 @default.
- W4320490014 cites W3047915982 @default.
- W4320490014 cites W3106058934 @default.
- W4320490014 cites W3159272838 @default.
- W4320490014 cites W3165747682 @default.
- W4320490014 cites W3176064512 @default.
- W4320490014 cites W3190445083 @default.
- W4320490014 cites W3201633949 @default.
- W4320490014 cites W4211167126 @default.
- W4320490014 cites W4213288903 @default.
- W4320490014 cites W4213385218 @default.
- W4320490014 cites W4224444655 @default.